BridgeBio Pharma
BBIO
$29.97
Share price
3.52%
Change (1 day)
101.95%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - P/B ratio
P/B ratio as of May 2024 : -5.41
According to BridgeBio Pharma
's latest financial reports the company has a price-to-book ratio of -5.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BridgeBio Pharma - P/B ratio (from 2019 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -5.23 | 471.74% |
| 2022-12-31 | -0.9150 | -67.74% |
| 2021-12-31 | -2.84 | -103.51% |
| 2020-12-31 | 80.9 | 788.16% |
| 2019-12-31 | 9.11 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6773 | -112.52% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -136.22% | 🇺🇸 USA |